drugset / Trial / NCT06042192
Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.
Phase 1
Completed
80 enrolled
Teikoku Seiyaku Co., Ltd.
CRM Biometrics GmbH · collabClinSearch · collabClinigen Clinical Supplies Management GmbH · collabSocraMetrics GmbH · collabSocraTec R&D GmbH · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is a multi center, multiple dose, open label trial to evaluate the adhesion of TK-254RX in healthy volunteers. The primary purpose of this study is to evaluate the adhesion of TK-254RX. Secondary purpose is to show TK-254RX is safe and to explore and compare adhesion assessment methods.
Timeline
- Start
- 2023-09-14
- Primary completion
- 2023-11-09
- Completion
- 2023-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esflurbiprofen | Small molecule | — | Topical |
Indications
No indication recorded.